FGF21 and coronary artery disorder: FGF-21 gene expression is reduced in adipose tissue from patients with multivessel coronary artery disease associated with T2DM and enhanced in adipose tissue from patients undergoing cardiac surgery, suggesting a protective effect of FGF-21 against inflammation associated with cardiac surgery (46, 47).